临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2009年
7期
65-66
,共2页
小儿肺炎%心力衰竭%疗效%纳络酮%西地兰
小兒肺炎%心力衰竭%療效%納絡酮%西地蘭
소인폐염%심력쇠갈%료효%납락동%서지란
children pneumonia%heart failure%efficacy%naloxone%cedilanid
目的 分析小儿肺炎并心力衰竭的临床特征,探讨其治疗方法及随访结果.方法 搜集2006年8月至2008年10月我院收治的肺炎并心力衰竭的患儿64例,并随机分为A、B、C三组,A、B组各20例,C组24例,三组均进行常规治疗,A组加用纳络酮,B组加用西地兰,C组加用纳络酮和西地兰,观察比较三组的疗效.结果 A组:显效11例.有效5例,无效4例;B组:显效13例.有效4例,无效3例:C组:显效17例,有效6例,无效1例.C组疗效与A、B组疗效相比较均有显著性差异(P<0.01).结论 纳络酮与西地兰联合使用治疗小儿肺炎并心力衰竭有相互协同的作用,促进病情恢复,疗效可靠,值得临床推广应用.
目的 分析小兒肺炎併心力衰竭的臨床特徵,探討其治療方法及隨訪結果.方法 搜集2006年8月至2008年10月我院收治的肺炎併心力衰竭的患兒64例,併隨機分為A、B、C三組,A、B組各20例,C組24例,三組均進行常規治療,A組加用納絡酮,B組加用西地蘭,C組加用納絡酮和西地蘭,觀察比較三組的療效.結果 A組:顯效11例.有效5例,無效4例;B組:顯效13例.有效4例,無效3例:C組:顯效17例,有效6例,無效1例.C組療效與A、B組療效相比較均有顯著性差異(P<0.01).結論 納絡酮與西地蘭聯閤使用治療小兒肺炎併心力衰竭有相互協同的作用,促進病情恢複,療效可靠,值得臨床推廣應用.
목적 분석소인폐염병심력쇠갈적림상특정,탐토기치료방법급수방결과.방법 수집2006년8월지2008년10월아원수치적폐염병심력쇠갈적환인64례,병수궤분위A、B、C삼조,A、B조각20례,C조24례,삼조균진행상규치료,A조가용납락동,B조가용서지란,C조가용납락동화서지란,관찰비교삼조적료효.결과 A조:현효11례.유효5례,무효4례;B조:현효13례.유효4례,무효3례:C조:현효17례,유효6례,무효1례.C조료효여A、B조료효상비교균유현저성차이(P<0.01).결론 납락동여서지란연합사용치료소인폐염병심력쇠갈유상호협동적작용,촉진병정회복,료효가고,치득림상추엄응용.
Objective To analyze the clinical features of children with pneumonia and heart failure, and to explore the treatment and follow-up resnits. Methods 64 cases of children with pneumonia combined with heart failure from August 2006 to October 2008 in our hospital were randomly divided into A, B, C groups. A, B groups were 20 cases each, C group was 24 cases. On the basis of conventional treatment in three groups, A group added with naloxone, B group with cedilanid, C group with naloxone and cedilanid, to observe and compare the efficacy of the three groups. Results A group: 11 cases had obvious effect, 5 cases were effective, 4 cases invalid; B group: 13 cases had obvious effect, effective in 4 cases, 3 cases of invalid; C group: 17 cases had obvious effect, effective in 6 cases, ineffective in 1 case. In contrast to A, B groups, the efficacy of group C was significantly different (P<0.01). Conclusions Naloxone combined with cedilanid treatment for children with pneumonia and heart failure have a mutual synergistic role in promoting the resumption of the disease, which has reliable efficacy and is worthy of clinical application.